Cite
MLA Citation
Hai-Yuan Yang et al.. “Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer.” Scientific reports, vol. 7, no. 1, 2017, pp. 1–8. http://access.bl.uk/ark:/81055/vdc_100084791943.0x0000de